DL-PENICILLAMINE
DL-PENICILLAMINE Basic information
- Product Name:
- DL-PENICILLAMINE
- Synonyms:
-
- 3-mercapto-dl-valin
- 3-mercapto-dl-valine
- dl-3-mercaptovaline
- dl-valin
- 3,3-Dimethyl-DL-cysteine~3-Mercapto-DL-valine
- DL-PENICILLAMINE, 99+%
- DL-PENICILLAMINE, 98+%
- AKOS NCG1-0051
- CAS:
- 52-66-4
- MF:
- C5H11NO2S
- MW:
- 149.21
- EINECS:
- 200-147-2
- Product Categories:
-
- Amino Acids
- Antibiotics
- Analytical Chemistry
- Biochemistry
- Ligands for Pharmaceutical Research
- non-Proteinorganic Amino Acids
- Radiopharmaceutical Chemistry (Chelating Reagents)
- Mol File:
- 52-66-4.mol
DL-PENICILLAMINE Chemical Properties
- Melting point:
- 204-208 °C(lit.)
- Boiling point:
- 251.8±35.0℃ (760 Torr)
- Density
- 1.204±0.06 g/cm3 (20 ºC 760 Torr)
- refractive index
- 1.5216 (estimate)
- Flash point:
- 106.1±25.9℃
- storage temp.
- Keep in dark place,Sealed in dry,2-8°C
- solubility
- Methanol (Slightly), Water (Soluble)
- pka
- pK: 1.8 (carboxyl); 7.9 (a-amino); 10.5 (b-thiol)
- form
- solid
- Water Solubility
- Soluble in ethanol, hot water and sodium hydroxide.
- Merck
- 14,7088
- BRN
- 2039817
- CAS DataBase Reference
- 52-66-4(CAS DataBase Reference)
Safety Information
- Hazard Codes
- Xn
- Risk Statements
- 22-36/37/38-40-20/21/22
- Safety Statements
- 26-36-22
- WGK Germany
- 3
- RTECS
- YV9445000
- HS Code
- 29309099
- Toxicity
- LD50 orally in rats: 365 mg/kg (Jaffe)
MSDS
- Language:English Provider:SigmaAldrich
- Language:English Provider:ACROS
- Language:English Provider:ALFA
DL-PENICILLAMINE Usage And Synthesis
Application in Rheumatic Arthritis
Penicillamine onset may be seen in 1 to 3 months, and most responses occur within 6 months. Early adverse effects include skin rash, metallic taste, hypogeusia, stomatitis, anorexia, nausea, vomiting, and dyspepsia. Glomerulonephritis may occur, which manifests as proteinuria and hematuria. Penicillamine is usually reserved for patients who are resistant to other therapies because of the rare but potentially serious induction of autoimmune diseases (e.g., Goodpasture’s syndrome, myasthenia gravis).
Chemical Properties
white to almost white crystalline powder
Uses
antirheumatic, chelating agent (copper), Wilson's desease treatment
Uses
DL-Penicillamine is a penicillin metabolite used in the treatment of Wilson’s disease, Cystinuria, Scleroderma and arsenic poisoning.
Definition
ChEBI: An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Safety Profile
Poison by ingestion and intraperitoneal routes. Mutation data reported. When heated to decomposition it emits toxic fumes of SOx and NOx.
DL-PENICILLAMINESupplier
- Tel
- 86-13062552990 13062552990
- sales@aldone.com.cn
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 021-61259108 18621169109
- market03@meryer.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 400-6106006
- saleschina@alfa-asia.com
DL-PENICILLAMINE(52-66-4)Related Product Information
- Ampicillin
- DL-4-Chlorophenylalanine
- DL-4-Cyanophenylalanine
- 2-AMINO-3-(3-METHOXY-PHENYL)-PROPIONIC ACID
- 2-Bromo-DL-Phenylalanine
- DL-3-(4-Fluorophenyl)alanine
- Mecillinam
- 6-Aminopenicillanic acid
- D-Penicillamine
- Dicloxacillin sodium
- DL-PENICILLAMINE
- Penicillin G potassium salt
- N-Acetyl-DL-penicillamine hemihydarate,N-ACETYL-DL-PENICILLAMINE 98%,N-ACETYL-DL-PENICILLAMINE,ACETYL-DL-PENICILLAMINE, N-
- Mezlocillin
- D-PENICILLAMINE DISULFIDE
- OXACILLIN SODIUM
- Cloxacillin-13C4 SodiuM Salt
- S-Benzyl-DL-Penicillamine